159 related articles for article (PubMed ID: 34871638)
1. Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use.
Ellis JD; Rabinowitz JA; Wells J; Liu F; Finan PH; Stein MD; Ii DGA; Hobelmann GJ; Huhn AS
J Affect Disord; 2022 Feb; 299():223-232. PubMed ID: 34871638
[TBL] [Abstract][Full Text] [Related]
2. Correlates and consequences of anxiety and depressive symptom trajectories during early treatment for alcohol use.
Rabinowitz JA; Ellis JD; Wells J; Strickland JC; Maher BS; Hobelmann JG; Huhn A
Alcohol; 2023 May; 108():44-54. PubMed ID: 36473635
[TBL] [Abstract][Full Text] [Related]
3. Identifying patterns of pain, depression, anxiety, interpersonal trauma exposure, and nonmedical prescription opioid use: Latent class analysis among patients with chronic pain.
Short NA; Patidar S; Margolies S; Goetzinger A; Chidgey B; Austin AE
Pain Med; 2024 Apr; 25(4):275-282. PubMed ID: 38092363
[TBL] [Abstract][Full Text] [Related]
4. Depression and Opioid Misuse in Elderly Individuals With Chronic Pain: A Latent Class Analysis.
Yan Z; Chang L; Zhang Q; Li C; Li Y
Pain Manag Nurs; 2022 Oct; 23(5):602-607. PubMed ID: 35283065
[TBL] [Abstract][Full Text] [Related]
5. Increases in primary opioid use disorder diagnoses co-occurring with anxiety or depressive disorder diagnoses in mental health treatment in the United States, 2015-2019.
Ware OD; Ellis JD; Strain EC; Antoine DG; Martinez S; Bergeria CL
Drug Alcohol Depend; 2023 Dec; 253():111022. PubMed ID: 37977041
[TBL] [Abstract][Full Text] [Related]
6. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.
McHugh RK; Votaw VR; Bogunovic O; Karakula SL; Griffin ML; Weiss RD
Addict Behav; 2017 Feb; 65():283-288. PubMed ID: 27575980
[TBL] [Abstract][Full Text] [Related]
7. Trajectories of symptoms of anxiety and depression among people on sick leave with mood or anxiety disorders: Secondary analysis from a randomized controlled trial.
Hellström L; Madsen T; Nordentoft M; Eplov LF
J Psychiatr Res; 2021 May; 137():250-257. PubMed ID: 33714077
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.
Vest N; Wenzel K; Choo TH; Pavlicova M; Rotrosen J; Nunes E; Lee JD; Fishman M
Am J Addict; 2023 May; 32(3):291-300. PubMed ID: 36645265
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses.
Goldner EM; Lusted A; Roerecke M; Rehm J; Fischer B
Addict Behav; 2014 Mar; 39(3):520-31. PubMed ID: 24333033
[TBL] [Abstract][Full Text] [Related]
10. Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study.
Fancourt D; Steptoe A; Bu F
Lancet Psychiatry; 2021 Feb; 8(2):141-149. PubMed ID: 33308420
[TBL] [Abstract][Full Text] [Related]
11. Anxiety, Depression, and Opioid Misuse Among Adults With Chronic Pain: The Role of Anxiety Sensitivity.
Rogers AH; Garey L; Bakhshaie J; Viana AG; Ditre JW; Zvolensky MJ
Clin J Pain; 2020 Nov; 36(11):862-867. PubMed ID: 32769415
[TBL] [Abstract][Full Text] [Related]
12. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
13. Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.
Latif ZE; Šaltyte Benth J; Solli KK; Opheim A; Kunoe N; Krajci P; Sharma-Haase K; Tanum L
JAMA Psychiatry; 2019 Feb; 76(2):127-134. PubMed ID: 30566177
[TBL] [Abstract][Full Text] [Related]
14. Trajectories of depressive symptoms in young and middle-aged men who have sex with men with new HIV-diagnosis: a 1-year prospective cohort study in Beijing, China.
Li X; Liu Y; Han J; Lin K; Bai X; Lu F
Front Public Health; 2023; 11():1244624. PubMed ID: 37915822
[TBL] [Abstract][Full Text] [Related]
15. Preexisting mental health disorders and risk of opioid use disorder in young people: A case-control study.
Marshall T; Olson K; Youngson E; Abba-Aji A; Li XM; Vohra S; Lewanczuk R
Early Interv Psychiatry; 2023 Oct; 17(10):963-973. PubMed ID: 36792950
[TBL] [Abstract][Full Text] [Related]
16. Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids.
Brown JL; Cochran G; Bryan MA; Charron E; Winhusen TJ
Subst Abus; 2022; 43(1):1110-1115. PubMed ID: 35499399
[No Abstract] [Full Text] [Related]
17. The impact of depression on opioid withdrawal symptoms among smokers with opioid use disorder receiving medication-assisted opioid detoxification.
Abarno CN; Chapman HM; Copeland AL
Exp Clin Psychopharmacol; 2023 Apr; 31(2):370-377. PubMed ID: 36074624
[TBL] [Abstract][Full Text] [Related]
18. Opioid and Cannabis Co-Use among Adults With Chronic Pain: Relations to Substance Misuse, Mental Health, and Pain Experience.
Rogers AH; Bakhshaie J; Buckner JD; Orr MF; Paulus DJ; Ditre JW; Zvolensky MJ
J Addict Med; 2019; 13(4):287-294. PubMed ID: 30557213
[TBL] [Abstract][Full Text] [Related]
19. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
20. Comorbid Prolonged Grief, PTSD, and Depression Trajectories for Bereaved Family Surrogates.
Wen FH; Prigerson HG; Chou WC; Huang CC; Hu TH; Chiang MC; Chuang LP; Tang ST
JAMA Netw Open; 2023 Nov; 6(11):e2342675. PubMed ID: 37948078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]